Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Abraham

Showing results (811-820 of 932) with videos related to

Pageof 94
Sort By:
European Journal of Heart Failure|May 1, 2020
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHEREPooja Dewan, Alice Jackson, Pardeep S Jhund, et al.
The American Journal of Medicine|January 25, 2006
Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational StudyAdam Strunk, Vikas Bhalla, Paul Clopton, et al.
Journal of Cardiac Failure|August 1, 2009
The rationale for an acute heart failure syndromes clinical trials networkSean P Collins, Phillip D Levy, Christopher J Lindsell, et al.
European Journal of Heart Failure|July 29, 2020
Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERESøren Lund Kristensen, Davide Castagno, Li Shen, et al.
JACC. Heart Failure|July 30, 2021
Impact of Diabetes on Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: COAPT TrialBahira Shahim, Ori Ben-Yehuda, Shmuel Chen, et al.
European Journal of Heart Failure|April 1, 2024
Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trialJosep Rodés-Cabau, JoAnn Lindenfeld, William T Abraham, et al.
The New England Journal of Medicine|June 14, 2002
Cardiac resynchronization in chronic heart failureWilliam T Abraham, Westby G Fisher, Andrew L Smith, et al.
JACC. Cardiovascular Interventions|October 6, 2022
Prediction of Death or HF Hospitalization in Patients With Severe FMR: The COAPT Risk ScoreNeeraj Shah, Mahesh V Madhavan, William A Gray, et al.
International Journal of Cardiology|May 28, 2014
Current challenges for clinical trials of cardiovascular medical devicesFaiez Zannad, Wendy Gattis Stough, Ileana L Piña, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-AnalysisNishkala Shivakumar, Daniel J Friedman, Marat Fudim, et al.
Pageof 94

Showing results (811-820 of 932) with videos related to

Sort By:
Pageof 94
European Journal of Heart Failure|May 1, 2020
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHEREPooja Dewan, Alice Jackson, Pardeep S Jhund, et al.
The American Journal of Medicine|January 25, 2006
Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational StudyAdam Strunk, Vikas Bhalla, Paul Clopton, et al.
Journal of Cardiac Failure|August 1, 2009
The rationale for an acute heart failure syndromes clinical trials networkSean P Collins, Phillip D Levy, Christopher J Lindsell, et al.
European Journal of Heart Failure|July 29, 2020
Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERESøren Lund Kristensen, Davide Castagno, Li Shen, et al.
JACC. Heart Failure|July 30, 2021
Impact of Diabetes on Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: COAPT TrialBahira Shahim, Ori Ben-Yehuda, Shmuel Chen, et al.
European Journal of Heart Failure|April 1, 2024
Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trialJosep Rodés-Cabau, JoAnn Lindenfeld, William T Abraham, et al.
The New England Journal of Medicine|June 14, 2002
Cardiac resynchronization in chronic heart failureWilliam T Abraham, Westby G Fisher, Andrew L Smith, et al.
JACC. Cardiovascular Interventions|October 6, 2022
Prediction of Death or HF Hospitalization in Patients With Severe FMR: The COAPT Risk ScoreNeeraj Shah, Mahesh V Madhavan, William A Gray, et al.
International Journal of Cardiology|May 28, 2014
Current challenges for clinical trials of cardiovascular medical devicesFaiez Zannad, Wendy Gattis Stough, Ileana L Piña, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-AnalysisNishkala Shivakumar, Daniel J Friedman, Marat Fudim, et al.
Pageof 94